For example, we identified in the HMF breast metastasis series significantly recurrent mutations of CDKN1A (known driver in bladder cancer), MAX (known in paragangliomas, endometrioid and colon carcinomas) and CDK12 (known in ovarian cancer). This evidence concerns the gene CDKN1A and ovarian carcinoma.